Latest News in the Life Sciences Industry
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
GlobeNewswire
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
01 Jun 2026
PR Newswire Association LLC.
Driving Innovation, Empowering Partners: ACROBiosystems Showcases Comprehensive CGT Solutions Anchored by GMP Capabilities at Bio Korea 2026
01 Jun 2026
GlobeNewswire
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
01 Jun 2026
GlobeNewswire
Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions
01 Jun 2026
GlobeNewswire
Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology
01 Jun 2026
GlobeNewswire
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
31 May 2026
GlobeNewswire
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
29 May 2026
GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
29 May 2026
GlobeNewswire
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
29 May 2026
GlobeNewswire
Sequana Medical announces results of Annual General Meeting of Shareholders
28 May 2026
GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
28 May 2026
GlobeNewswire
Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development
28 May 2026
GlobeNewswire
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant (ORSERDU®) in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual M
28 May 2026
GlobeNewswire
Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
28 May 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan